Elevated protein kinase C-δ contributes to aneurysm pathogenesis through stimulation of apoptosis and inflammatory

Stephanie Morgan1, Dai Yamanouchi, Calvin Harberg

  • 1Division of Vascular Surgery, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.

Abstract

Insights

Protein kinase C-delta (PKCδ) drives abdominal aortic aneurysm (AAA) by promoting smooth muscle cell apoptosis and inflammation. Inhibiting PKCδ could be a therapeutic strategy for AAA.

Area of Science:

  • Cardiovascular Biology
  • Vascular Inflammation
  • Cell Death Pathways

Background:

  • Smooth muscle cell (SMC) apoptosis is a key feature in abdominal aortic aneurysm (AAA) pathogenesis.
  • SMC apoptosis has been previously linked to the stimulation of pro-inflammatory signaling in AAA models.

Purpose of the Study:

  • To investigate the role of protein kinase C-delta (PKCδ), a known apoptotic mediator, in AAA development.
  • To determine if PKCδ regulates SMC apoptosis and pro-inflammatory signals contributing to AAA pathogenesis.

Main Methods:

  • Induction of experimental AAA in mice using perivascular CaCl(2) administration.
  • Utilized PKCδ-deficient (PKCδ(-/-)) and wild-type mice, including aortic SMCs and dominant-negative PKCδ mutants.
  • Assessed aneurysmal expansion, SMC apoptosis, inflammation, and monocyte chemoattractant protein-1 (MCP-1) production.

Main Results:

  • PKCδ deficiency significantly reduced AAA expansion, SMC apoptosis, and inflammation compared to wild-type mice.
  • Restoration of PKCδ in deficient mice re-established aneurysm formation; dominant-negative PKCδ attenuated aneurysm in wild-type mice.
  • PKCδ(-/-) SMCs showed impaired MCP-1 production, which was restored by recombinant MCP-1, re-initiating inflammation and aneurysm.

Conclusions:

  • PKCδ is a critical mediator of SMC apoptosis and inflammation in a mouse model of AAA.
  • Upregulated PKCδ exacerbates AAA by increasing MCP-1 expression in SMCs, driving elastin degradation and dilatation.
  • Targeting PKCδ presents a potential therapeutic avenue for treating abdominal aortic aneurysms.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...